SCHEMBL11974146

SCHEMBL11974146

O=C(O)CCCCC1SCC2NC(O)NC21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 7/20 0.59
▸ LMNA P02545 3/20 0.59
▸ MEN1 O00255 2/20 0.59
▸ KMT2A Q03164 2/20 0.59
▸ L3MBTL1 Q9Y468 2/20 0.59
▸ ABL1 P00519 1/20 0.59
▸ PKM P14618 1/20 0.59
▸ IDE P14735 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ RIN1 Q13671 1/20 0.59
▸ HLCS P50747 6/20 0.38
▸ HSD17B10 Q99714 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ APEX1 P27695 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19054924 1.00 TDP1 (0.59) TDP1LMNAMEN1KMT2AL3MBTL1
SCHEMBL11983712 0.88 TDP1 (0.51) TDP1LMNAMEN1KMT2AL3MBTL1
SCHEMBL20342144 0.87 TDP1 (0.45) TDP1LMNAMEN1KMT2AL3MBTL1
SCHEMBL21390226 0.83 TDP1 (0.44) TDP1LMNAMEN1KMT2AL3MBTL1
SCHEMBL22473613 0.80 FAAH (0.42) TDP1LMNAMEN1KMT2AL3MBTL1
SCHEMBL22037753 0.80 HLCS (0.55) TDP1LMNAMEN1KMT2AL3MBTL1
SCHEMBL22364111 0.79 TDP1 (0.47) TDP1LMNAMEN1KMT2AL3MBTL1
SCHEMBL18881123 0.78 TDP1 (0.49) TDP1LMNAMEN1KMT2AL3MBTL1
SCHEMBL2608511 0.77 HLCS (0.39) TDP1LMNAMEN1KMT2AL3MBTL1
SCHEMBL14586595 0.77 TDP1 (0.61) TDP1LMNAMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220396584-A1 BIOTIN-CONTAINING MONOMERS AND ARTICLES FORMED THEREFROM SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2022-12-15 — — US disclosed
US-20120207684-A1 COMPOSITION AND METHODS FOR IMAGING CELLS CASE WESTERN RESERVE UNIVERSITY 2012-08-16 — — US disclosed
US-20120207684-A1 COMPOSITION AND METHODS FOR IMAGING CELLS CASE WESTERN RESERVE UNIVERSITY 2012-08-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120207684-A1 COMPOSITION AND METHODS FOR IMAGING CELLS MCL1, TP53, HNRNPAB TDP1 3017/4885LMNA 808/4885MEN1 413/4885
US-20220396584-A1 BIOTIN-CONTAINING MONOMERS AND ARTICLES FORMED THEREFROM BTD, BPGM, STAMBP TDP1 3418/4885LMNA 2540/4885MEN1 2641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback